CD4 and lung cancer: A randomized controlled double-blind trial in postoperative patients with breast and lung cancer showed that treatment with G. lucidum spore powder (2000 mg, twice daily for six weeks) increased CD3+ CD4+ CD3+ HLADR- cell types, whereas decreased CD4+ CD25+ Treg, CD3+ HLADR+ cell types compared to control [64].